CS Diagnostics Corp CSDX

$0.01 +0.00 (80.33%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
5,300
Avg volume
113,130
Day's range
$0.01 – $0.01
Shares out
—
Stochastic %K
20%
Beta
—
Analysts
—
Price target
—

Price

Company profile

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The...

Show more

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, Wyoming.

Industry
Medical Devices
Sector
Healthcare
Phone
307 395 7333
Website
https://csdcorp.us/
Address
1603 Capitol Avenue, Cheyenne, United States

Latest news

No headlines yet.